Literature DB >> 8923044

Borrelia burgdorferi DNA in the urine of treated patients with chronic Lyme disease symptoms. A PCR study of 97 cases.

M E Bayer1, L Zhang, M H Bayer.   

Abstract

The presence of Borrelia burgdorferi DNA was established by PCR from urine samples of 97 patients clinically diagnosed as presenting with symptoms of chronic Lyme disease. All patients had shown erythema chronica migrans following a deer tick bite. Most of the patients had been antibiotic-treated for extended periods of time. We used three sets of primer pairs with DNA sequences for the gene coding of outer surface protein A (OspA) and of a genomic sequence of B. burgdorferi to study samples of physician-referred patients from the mideastern USA. Controls from 62 healthy volunteers of the same geographic areas were routinely carried through the procedures in parallel with patients' samples. Of the 97 patients, 72 (74.2%) were found with positive PCR and the rest with negative PCR. The 62 healthy volunteers were PCR negative. It is proposed that a sizeable group of patients diagnosed on clinical grounds as having chronic Lyme disease may still excrete Borrelia DNA, and may do so in spite of intensive antibiotic treatment.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8923044     DOI: 10.1007/bf01716077

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  34 in total

1.  Detection of Borrelia burgdorferi DNA by the polymerase chain reaction.

Authors:  S L Nielsen; K K Young; A G Barbour
Journal:  Mol Cell Probes       Date:  1990-02       Impact factor: 2.365

2.  Evolution of the serologic response to Borrelia burgdorferi in treated patients with culture-confirmed erythema migrans.

Authors:  M E Aguero-Rosenfeld; J Nowakowski; S Bittker; D Cooper; R B Nadelman; G P Wormser
Journal:  J Clin Microbiol       Date:  1996-01       Impact factor: 5.948

3.  A specific and sensitive assay for the Lyme disease spirochete Borrelia burgdorferi using the polymerase chain reaction.

Authors:  P A Rosa; T G Schwan
Journal:  J Infect Dis       Date:  1989-12       Impact factor: 5.226

4.  Isolation and characterization of the Lyme disease spirochete from the skin of patients with erythema chronicum migrans.

Authors:  B W Berger; M H Kaplan; I R Rothenberg; A G Barbour
Journal:  J Am Acad Dermatol       Date:  1985-09       Impact factor: 11.527

5.  Immune capture and detection of Borrelia burgdorferi antigens in urine, blood, or tissues from infected ticks, mice, dogs, and humans.

Authors:  D W Dorward; T G Schwan; C F Garon
Journal:  J Clin Microbiol       Date:  1991-06       Impact factor: 5.948

6.  Demonstration of Borrelia burgdorferi DNA in urine samples from healthy humans whose sera contain B. burgdorferi-specific antibodies.

Authors:  H Karch; H I Huppertz; M Böhme; H Schmidt; D Wiebecke; A Schwarzkopf
Journal:  J Clin Microbiol       Date:  1994-09       Impact factor: 5.948

7.  Circulating Borrelia burgdorferi in patients with acute Lyme disease: results of blood cultures and serum DNA analysis.

Authors:  F R Wallach; A L Forni; J Hariprashad; M Y Stoeckle; C R Steinberg; L Fisher; S E Malawista; H W Murray
Journal:  J Infect Dis       Date:  1993-12       Impact factor: 5.226

8.  Identification of an uncultivable Borrelia species in the hard tick Amblyomma americanum: possible agent of a Lyme disease-like illness.

Authors:  A G Barbour; G O Maupin; G J Teltow; C J Carter; J Piesman
Journal:  J Infect Dis       Date:  1996-02       Impact factor: 5.226

9.  Mutations in the p53 gene are frequent in primary, resected non-small cell lung cancer. Lung Cancer Study Group.

Authors:  I Chiba; T Takahashi; M M Nau; D D'Amico; D T Curiel; T Mitsudomi; D L Buchhagen; D Carbone; S Piantadosi; H Koga
Journal:  Oncogene       Date:  1990-10       Impact factor: 9.867

10.  Isolation and cultivation of Lyme disease spirochetes.

Authors:  A G Barbour
Journal:  Yale J Biol Med       Date:  1984 Jul-Aug
View more
  13 in total

1.  A proposal for the reliable culture of Borrelia burgdorferi from patients with chronic Lyme disease, even from those previously aggressively treated.

Authors:  S E Phillips; L H Mattman; D Hulínská; H Moayad
Journal:  Infection       Date:  1998 Nov-Dec       Impact factor: 3.553

Review 2.  Chronic Lyme disease.

Authors:  Paul M Lantos
Journal:  Infect Dis Clin North Am       Date:  2015-06       Impact factor: 5.982

3.  A new animal model for studying Lyme disease spirochetes in a mammalian host-adapted state.

Authors:  D R Akins; K W Bourell; M J Caimano; M V Norgard; J D Radolf
Journal:  J Clin Invest       Date:  1998-05-15       Impact factor: 14.808

4.  Quantitative detection of Borrelia burgdorferi by real-time PCR.

Authors:  A Pahl; U Kühlbrandt; K Brune; M Röllinghoff; A Gessner
Journal:  J Clin Microbiol       Date:  1999-06       Impact factor: 5.948

5.  Detection and molecular typing of Borrelia burgdorferi sensu lato in Ixodes ricinus ticks and in different patient samples from southwest Germany.

Authors:  D Schaarschmidt; R Oehme; P Kimmig; R D Hesch; S Englisch
Journal:  Eur J Epidemiol       Date:  2001       Impact factor: 8.082

Review 6.  Chronic Lyme disease: a review.

Authors:  Adriana Marques
Journal:  Infect Dis Clin North Am       Date:  2008-06       Impact factor: 5.982

7.  Implications of gender in chronic Lyme disease.

Authors:  Gary P Wormser; Eugene D Shapiro
Journal:  J Womens Health (Larchmt)       Date:  2009-06       Impact factor: 2.681

8.  Diagnostic value of PCR for detection of Borrelia burgdorferi in skin biopsy and urine samples from patients with skin borreliosis.

Authors:  S Brettschneider; H Bruckbauer; N Klugbauer; H Hofmann
Journal:  J Clin Microbiol       Date:  1998-09       Impact factor: 5.948

9.  Lyme disease: the next decade.

Authors:  Raphael B Stricker; Lorraine Johnson
Journal:  Infect Drug Resist       Date:  2011-01-07       Impact factor: 4.003

10.  Identification of Additional Anti-Persister Activity against Borrelia burgdorferi from an FDA Drug Library.

Authors:  Jie Feng; Megan Weitner; Wanliang Shi; Shuo Zhang; David Sullivan; Ying Zhang
Journal:  Antibiotics (Basel)       Date:  2015-09-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.